Concord Drugs Ltd
BSE:538965
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Concord Drugs Ltd
BSE:538965
|
IN |
|
E
|
Energy Resources Of Australia Ltd
OTC:EGRAF
|
AU |
|
L&T Finance Ltd
BSE:533519
|
IN |
|
BYD Co Ltd
LSE:0HKY
|
CN |
|
U
|
US Bancorp
XHAM:UB5
|
US |
|
Bumi Serpong Damai Tbk PT
OTC:BSPDF
|
ID |
|
General Inc
TSE:6755
|
JP |
|
Ping An Insurance (Group) Co of China Ltd
SSE:601318
|
CN |
|
Deere & Co
NYSE:DE
|
US |
|
Weimob Inc
HKEX:2013
|
CN |
|
A
|
AXA SA
XHAM:AXA
|
FR |
|
ServiceNow Inc
NYSE:NOW
|
US |
|
E
|
Enwei Pharmaceutical Co Ltd
SZSE:301331
|
CN |
|
Grupo Aeroportuario del Pacifico SAB de CV
OTC:GPAEF
|
MX |
|
Magnite Inc
NASDAQ:MGNI
|
US |
|
Coherent Corp
MIL:1COHR
|
US |
|
N
|
Nextera Energy Inc
LSE:0K80
|
US |
|
Penske Automotive Group Inc
NYSE:PAG
|
US |
|
H
|
Hurxley Corp
TSE:7561
|
JP |
|
J
|
Jasuindo Tiga Perkasa Tbk PT
IDX:JTPE
|
ID |
|
G
|
Genmab A/S
DUS:GE9
|
DK |
|
L
|
LEWAG Holding AG
F:KGR
|
DE |
|
E
|
Endeavour Silver Corp
XHAM:EJD
|
CA |
|
C
|
Charles River Laboratories International Inc
XMUN:RV6
|
US |
Bankruptcy Probability
Concord Drugs Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Concord Drugs Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
C
|
Concord Drugs Ltd
BSE:538965
|
942.8m INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
655.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
253.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
167.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
129B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
100.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Concord Drugs Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Concord Drugs Ltd has total debt of 18.1m INR. This includes both short-term (0 INR) and long-term (18.1m INR) debt.
You can find a full breakdown on its Balance Sheet.